Scabies on rise: Optimising treatment to avoid lack of response

+Practice
In print
Dermatology

Scabies on rise: Optimising treatment to avoid lack of response

By Caroline Mahon
Fig 1 Scabies
Classical digital scabies papules in a case of failed topical treatment in a young person [Images: Supplied]

Dermatologist Caroline Mahon provides updates on how to optimise topical permethrin treatment for scabies and how to use oral ivermectin in children

Key points, Cases of scabies may be increasing, with associated treatment failures. Permethrin 5 per cent is the recommended first-line treatment, and cream is , Pract Green w Pale Yellow
References

1. Simonart T, Lam Hoai XL. Escalating threat of drug-resistant human scabies: Current insights and future directions. J Clin Med 2024;13(18):5511.

2. Ivens UI, Steinkjer B, Serup J, Tetens V. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001;145(2):264–67.

3. Rhodes LE, Diffey BL. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents. Br J Dermatol 1997;136(1):12–17.

4. Gwee A, Steer A, Phongluxa K, et al. Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trial. Lancet Reg Health West Pac 2024;49:101144.

5. Jittamala P, Monteiro W, Smit MR, et al. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? PLoS Negl Trop Dis 2021;15(3):e0009144.

6. Levy M, Martin L, Bursztejn AC, et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol 2020;182(4):1003–06.